These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38278978)

  • 1. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20.
    Fatima I; Ahmad R; Barman S; Gowrikumar S; Pravoverov K; Primeaux M; Fisher KW; Singh AB; Dhawan P
    Br J Cancer; 2024 Apr; 130(6):1046-1058. PubMed ID: 38278978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling.
    Anand S; Nedeva C; Chitti SV; Fonseka P; Kang T; Gangoda L; Tabassum NI; Abdirahman S; Arumugam TV; Putoczki TL; Kumar S; Mathivanan S
    Cell Death Dis; 2023 Dec; 14(12):828. PubMed ID: 38097550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
    Lee JH; Lee SW
    Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
    Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
    Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
    J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
    Sakatani A; Sonohara F; Goel A
    Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2.
    Chen W; Chen Y; Hui T
    J Chemother; 2023 Oct; 35(6):539-549. PubMed ID: 36546770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
    Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
    Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
    Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
    Lavitrano M; Ianzano L; Bonomo S; Cialdella A; Cerrito MG; Pisano F; Missaglia C; Giovannoni R; Romano G; McLean CM; Voest EE; D'Amato F; Noli B; Ferri GL; Agostini M; Pucciarelli S; Helin K; Leone BE; Canzonieri V; Grassilli E
    J Pathol; 2020 Feb; 250(2):134-147. PubMed ID: 31518438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer.
    Song M; Yang J; Di M; Hong Y; Pan Q; Du Y; Xiang T; Liu J; Tang Y; Wang Q; Li Y; He J; Chen H; Zhao J; Weng D; Zhang Y; Xia JC
    Theranostics; 2023; 13(5):1649-1668. PubMed ID: 37056569
    [No Abstract]   [Full Text] [Related]  

  • 18. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death.
    Petersen JSSM; Baird SK
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2945-2953. PubMed ID: 34148157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.